Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis.

Saved in:
Bibliographic Details
Title: Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis.
Authors: Gunes I; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, USA., Bernstein EJ; Department of Medicine, Division of Rheumatology, Columbia University Irving Medical Center, New York, USA., Cowper SE; Departments of Dermatology and Pathology, Yale School of Medicine, New Haven, USA., Panse G; Departments of Dermatology and Pathology, Yale School of Medicine, New Haven, USA., Pradhan N; Department of Medicine, Division of Rheumatology, Columbia University Irving Medical Center, New York, USA., Camacho LD; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, USA., Page N; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, USA., Bundschuh E; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, USA., Williams A; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, USA., Carns M; Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA., Aren K; Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA., Fantus S; Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA., Volkmann ER; David Geffen School of Medicine, Division of Rheumatology, University of California, los Angeles, Los Angeles, USA., Bukiri H; David Geffen School of Medicine, Division of Rheumatology, University of California, los Angeles, Los Angeles, USA., Correia C; Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA., Kolachalama VB; Boston University, Boston, USA., Wilson FP; Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, USA.; Department of Internal Medicine, Section of Nephrology, New Haven, USA., Mawe S; The Jackson Laboratory, Bar Harbor, USA., Mahoney JM; The Jackson Laboratory, Bar Harbor, USA., Hinchcliff M; Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, Yale School of Medicine, New Haven, USA. Monique.hinchcliff@yale.edu.; Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, USA. Monique.hinchcliff@yale.edu.
Source: Arthritis research & therapy [Arthritis Res Ther] 2025 Apr 11; Vol. 27 (1), pp. 85. Date of Electronic Publication: 2025 Apr 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1478-6362
DOI:10.1186/s13075-025-03508-9